找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

(版塊ONCOLOGY(腫瘤學(xué))版塊期刊總數(shù):80)
新窗
投票 ESCI期刊Memo-Magazine of European Medical Oncology 2024/2025影響因子:0.405 (MEMO-MAG EUR MED ONC) (1865-5041). (ONCOLOGY)(腫瘤學(xué)  ...234
Total Citations:239; 2023 JIF:0.405; JIFRank: 304/322 ; Rank-JIF: 304; Number-of-JIF:322; 5 Year JIF:0.442; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.4; Immediacy Index:0.2; Immediacy Index-dealt:0.245; 2023 JCI:0.1; JCI Rank: 303/322 ; Total Articles:29; JCI Quartile:Q4; JCI Percentile:6.06; Eigenfactor:0; Normalized Eigenfactor:0.068; Article Influence Score:0.092; JIF Percentile:5.7; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:77; % of Articles in Citable items:0.3766; Cited Half-Life:4.2; Citing Half-Life:3.1; % of OA Gold:0.4587; Publisher name:UNIV ILLINOIS PRESS; Publisher address:1325 S OAK ST, MC-566, CHAMPAIGN, Usa, IL, 6
投票 ESCI期刊Blood and Lymphatic Cancer-Targets and Therapy 2024/2025影響因子:3.943 (BLOOD LYMPHAT CANCER) (1179-9889). (ONCOLOGY)  ...234
Total Citations:138; 2023 JIF:3.943; JIFRank: 99/322 ; Rank-JIF: 99; Number-of-JIF:322; 5 Year JIF:3.303; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.9; Immediacy Index:0.6; Immediacy Index-dealt:0.642; 2023 JCI:0.57; JCI Rank: 188/322 ; Total Articles:2; JCI Quartile:Q3; JCI Percentile:41.77; Eigenfactor:0; Normalized Eigenfactor:0.052; Article Influence Score:0.863; JIF Percentile:69.4; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:7; % of Articles in Citable items:0.2857; Cited Half-Life:2.7; Citing Half-Life:6.5; % of OA Gold:1; Publisher name:ELSEVIER SCIENCE INC; Publisher address:STE 800, 230 PARK AVE, NEW YORK, USA, NY, 10169;
投票 ESCI期刊Blood Cancer Discovery 2024/2025影響因子:11.541 (BLOOD CANCER DISCOV) (2643-3230). (ONCOLOGY)(腫瘤學(xué))Emerging Sources Ci  ...234
Total Citations:1059; 2023 JIF:11.541; JIFRank: 24/322 ; Rank-JIF: 24; Number-of-JIF:322; 5 Year JIF:11.164; 5 Year JIF Quartile:Q1; JIF Without Self Cites:11.3; Immediacy Index:3.6; Immediacy Index-dealt:3.637; 2023 JCI:2.55; JCI Rank: 19/322 ; Total Articles:20; JCI Quartile:Q1; JCI Percentile:94.25; Eigenfactor:0.004; Normalized Eigenfactor:0.98; Article Influence Score:6.145; JIF Percentile:92.7; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:23; % of Articles in Citable items:0.8696; Cited Half-Life:2.2; Citing Half-Life:6.8; % of OA Gold:0.3548; Publisher name:NATL TAIWAN UNIV PRESS; Publisher address:NO 1 SECTION 4, ROOSEVELT RD, TAIP
投票 ESCI期刊Journal of Breast Imaging 2024/2025影響因子:2.123 (J BREAST IMAGING) (2631-6110). (ONCOLOGY)(腫瘤學(xué))Emerging Sources Cit  ...234
Total Citations:603; 2023 JIF:2.123; JIFRank: 221/322 ; Rank-JIF: 221; Number-of-JIF:322; 5 Year JIF:1.889; 5 Year JIF Quartile:Q4; JIF Without Self Cites:1.4; Immediacy Index:1.4; Immediacy Index-dealt:1.472; 2023 JCI:0.42; JCI Rank: 232/322 ; Total Articles:58; JCI Quartile:Q3; JCI Percentile:32.11; Eigenfactor:0.001; Normalized Eigenfactor:0.21; Article Influence Score:0.43; JIF Percentile:49.3; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:76; % of Articles in Citable items:0.7632; Cited Half-Life:2.5; Citing Half-Life:6.9; % of OA Gold:0.0833; Publisher name:RUSSIAN PRESIDENTIAL ACAD NATL ECONOMY & PUBLIC ADM (RANEPA); Publisher addres
投票 ESCI期刊South Asian Journal of Cancer 2024/2025影響因子:0.645 (SOUTH ASIAN J CANCER) (2278-330X). (ONCOLOGY)(腫瘤學(xué))Emerging Sou  ...234
Total Citations:645; 2023 JIF:0.645; JIFRank: 299/322 ; Rank-JIF: 299; Number-of-JIF:322; 5 Year JIF:0.944; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.6; Immediacy Index:0.1; Immediacy Index-dealt:0.139; 2023 JCI:0.13; JCI Rank: 300/322 ; Total Articles:68; JCI Quartile:Q4; JCI Percentile:6.99; Eigenfactor:0.001; Normalized Eigenfactor:0.109; Article Influence Score:0.19; JIF Percentile:7.3; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:76; % of Articles in Citable items:0.8947; Cited Half-Life:6.6; Citing Half-Life:9.3; % of OA Gold:0.9865; Publisher name:TORREY BOTANICAL SOC; Publisher address:810 E 10TH ST, LAWRENCE, USA, KS, 66044
投票 ESCI期刊JCO Clinical Cancer Informatics 2024/2025影響因子:3.324 (JCO CLIN CANCER INFO) (2473-4276). (ONCOLOGY)(腫瘤學(xué))Emerging S  ...234
Total Citations:2193; 2023 JIF:3.324; JIFRank: 118/322 ; Rank-JIF: 118; Number-of-JIF:322; 5 Year JIF:4.512; 5 Year JIF Quartile:Q2; JIF Without Self Cites:2.8; Immediacy Index:0.3; Immediacy Index-dealt:0.336; 2023 JCI:0.8; JCI Rank: 116/322 ; Total Articles:213; JCI Quartile:Q2; JCI Percentile:64.13; Eigenfactor:0.006; Normalized Eigenfactor:1.388; Article Influence Score:1.669; JIF Percentile:63.5; JIF Quartile:Q2; AIS Quartile:Q1; Citable Items:232; % of Articles in Citable items:0.9181; Cited Half-Life:3.5; Citing Half-Life:5.6; % of OA Gold:0.2179; Publisher name:ELSEVIER SCI LTD; Publisher address:125 London Wall, London, England, EC2Y
投票 ESCI期刊JCO Global Oncology 2024/2025影響因子:3.273 (JCO GLOB ONCOL) (NULL). (ONCOLOGY)(腫瘤學(xué))Emerging Sources Citation Index  ...234
Total Citations:1960; 2023 JIF:3.273; JIFRank: 129/322 ; Rank-JIF: 129; Number-of-JIF:322; 5 Year JIF:3.982; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.1; Immediacy Index:0.7; Immediacy Index-dealt:0.792; 2023 JCI:0.74; JCI Rank: 133/322 ; Total Articles:106; JCI Quartile:Q2; JCI Percentile:58.85; Eigenfactor:0.005; Normalized Eigenfactor:1.138; Article Influence Score:1.308; JIF Percentile:60.1; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:127; % of Articles in Citable items:0.8346; Cited Half-Life:2.9; Citing Half-Life:5.8; % of OA Gold:0.8941; Publisher name:WOLTERS KLUWER MEDKNOW PUBLICATIONS; Publisher address:WOLTERS KLUWER IND
投票 ESCI期刊Colorectal Cancer 2024/2025影響因子:2.715 (COLORECTAL CANCER) (1758-194X). (ONCOLOGY)(腫瘤學(xué))Emerging Sources Citation I  ...234
Total Citations:118; 2023 JIF:2.715; JIFRank: 163/322 ; Rank-JIF: 163; Number-of-JIF:322; 5 Year JIF:2.444; 5 Year JIF Quartile:Q3; JIF Without Self Cites:2.7; Immediacy Index:1; Immediacy Index-dealt:1.140; 2023 JCI:0.23; JCI Rank: 285/322 ; Total Articles:3; JCI Quartile:Q4; JCI Percentile:11.65; Eigenfactor:0; Normalized Eigenfactor:0.037; Article Influence Score:0.757; JIF Percentile:49.5; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:4; % of Articles in Citable items:0.75; Cited Half-Life:5.2; Citing Half-Life:5.8; % of OA Gold:0.7143; Publisher name:WILEY; Publisher address:111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774;
投票 ESCI期刊Uroonkoloji Bulteni-Bulletin of Urooncology 2024/2025影響因子:0.163 (UROONKOLOJI BUL) (2147-2270). (ONCOLOGY)(腫瘤學(xué))Eme  ...234
Total Citations:32; 2023 JIF:0.163; JIFRank: 318/322 ; Rank-JIF: 318; Number-of-JIF:322; 5 Year JIF:0.179; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.1; Immediacy Index:<0.1; Immediacy Index-dealt:0.012; 2023 JCI:0.03; JCI Rank: 317/322 ; Total Articles:27; JCI Quartile:Q4; JCI Percentile:1.71; Eigenfactor:0; Normalized Eigenfactor:0.006; Article Influence Score:0.018; JIF Percentile:1.4; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:31; % of Articles in Citable items:0.871; Cited Half-Life:NULL; Citing Half-Life:8.4; % of OA Gold:1; Publisher name:UNIV PENDIDIKAN SULTAN IDRIS, FAC MUSIC & PERFORMING ARTS; Publisher address:UNIV PENDI
投票 ESCI期刊Eurasian Journal of Medicine and Oncology 2024/2025影響因子:0.831 (EURASIAN J MED ONCOL) (NULL). (ONCOLOGY)(腫瘤學(xué))Emerg  ...234
Total Citations:211; 2023 JIF:0.831; JIFRank: 296/322 ; Rank-JIF: 296; Number-of-JIF:322; 5 Year JIF:0.826; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.8; Immediacy Index:0.1; Immediacy Index-dealt:0.187; 2023 JCI:0.36; JCI Rank: 255/322 ; Total Articles:35; JCI Quartile:Q4; JCI Percentile:20.96; Eigenfactor:0; Normalized Eigenfactor:0.062; Article Influence Score:0.147; JIF Percentile:8.2; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:45; % of Articles in Citable items:0.7778; Cited Half-Life:3.3; Citing Half-Life:7; % of OA Gold:0.9248; Publisher name:SPRINGER; Publisher address:ONE NEW YORK PLAZA, SUITE 4600 , NEW YORK, United State
投票 ESCI期刊International Cancer Conference Journal 2024/2025影響因子:0.531 (INT CANCER CONF J) (2192-3183). (ONCOLOGY)(腫瘤學(xué))Emerg  ...234
Total Citations:226; 2023 JIF:0.531; JIFRank: 302/322 ; Rank-JIF: 302; Number-of-JIF:322; 5 Year JIF:0.631; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.5; Immediacy Index:0.1; Immediacy Index-dealt:0.183; 2023 JCI:0.13; JCI Rank: 300/322 ; Total Articles:44; JCI Quartile:Q4; JCI Percentile:6.99; Eigenfactor:0; Normalized Eigenfactor:0.068; Article Influence Score:0.14; JIF Percentile:6.4; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:49; % of Articles in Citable items:0.898; Cited Half-Life:3.8; Citing Half-Life:8.2; % of OA Gold:0.1047; Publisher name:L N GUMILYOV EURASIAN NATL UNIV; Publisher address:PUSHKIN ST, 11, RM 210, ASTANA, K
投票 ESCI期刊Oncology and Therapy 2024/2025影響因子:3.222 (ONCOL THER) (2366-1070). (ONCOLOGY)(腫瘤學(xué))Emerging Sources Citation Index  ...234
Total Citations:476; 2023 JIF:3.222; JIFRank: 129/322 ; Rank-JIF: 129; Number-of-JIF:322; 5 Year JIF:3.292; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.2; Immediacy Index:0.5; Immediacy Index-dealt:0.533; 2023 JCI:0.45; JCI Rank: 225/322 ; Total Articles:19; JCI Quartile:Q3; JCI Percentile:30.28; Eigenfactor:0.001; Normalized Eigenfactor:0.188; Article Influence Score:0.857; JIF Percentile:60.1; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:26; % of Articles in Citable items:0.7308; Cited Half-Life:2.9; Citing Half-Life:5.1; % of OA Gold:1; Publisher name:NULL; Publisher address:NULL;
投票 ESCI期刊Oncology in Clinical Practice 2024/2025影響因子:0.368 (ONCOL CLIN PRACT) (2450-1654). (ONCOLOGY)(腫瘤學(xué))Emerging Sources  ...234
Total Citations:139; 2023 JIF:0.368; JIFRank: 309/322 ; Rank-JIF: 309; Number-of-JIF:322; 5 Year JIF:0.409; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.3; Immediacy Index:0.1; Immediacy Index-dealt:0.113; 2023 JCI:0.08; JCI Rank: 309/322 ; Total Articles:56; JCI Quartile:Q4; JCI Percentile:4.19; Eigenfactor:0; Normalized Eigenfactor:0.029; Article Influence Score:0.076; JIF Percentile:4.2; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:93; % of Articles in Citable items:0.6022; Cited Half-Life:4.5; Citing Half-Life:6.1; % of OA Gold:0.9829; Publisher name:TAYLOR & FRANCIS INC; Publisher address:530 WALNUT STREET, STE 850, PHILADELPHIA,
投票 ESCI期刊Advances in Radiation Oncology 2024/2025影響因子:2.234 (ADV RADIAT ONCOL) (NULL). (ONCOLOGY)(腫瘤學(xué))Emerging Sources Cit  ...234
Total Citations:2224; 2023 JIF:2.234; JIFRank: 209/322 ; Rank-JIF: 209; Number-of-JIF:322; 5 Year JIF:2.433; 5 Year JIF Quartile:Q3; JIF Without Self Cites:2.1; Immediacy Index:0.7; Immediacy Index-dealt:0.722; 2023 JCI:0.63; JCI Rank: 169/322 ; Total Articles:135; JCI Quartile:Q2; JCI Percentile:51.72; Eigenfactor:0.005; Normalized Eigenfactor:1.037; Article Influence Score:0.748; JIF Percentile:55.6; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:144; % of Articles in Citable items:0.9375; Cited Half-Life:3.3; Citing Half-Life:7.3; % of OA Gold:0.8154; Publisher name:SCIENDO; Publisher address:BOGUMILA ZUGA 32A, WARSAW, Poland, MAZOVIA, 01
投票 ESCI期刊International Journal of Breast Cancer 2024/2025影響因子:1.686 (INT J BREAST CANCER) (2090-3170). (ONCOLOGY)(腫瘤學(xué))Emer  ...234
Total Citations:517; 2023 JIF:1.686; JIFRank: 253/322 ; Rank-JIF: 253; Number-of-JIF:322; 5 Year JIF:1.939; 5 Year JIF Quartile:Q4; JIF Without Self Cites:1.6; Immediacy Index:1; Immediacy Index-dealt:1.109; 2023 JCI:0.4; JCI Rank: 241/322 ; Total Articles:7; JCI Quartile:Q3; JCI Percentile:25.31; Eigenfactor:0; Normalized Eigenfactor:0.055; Article Influence Score:0.43; JIF Percentile:21.6; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:7; % of Articles in Citable items:1; Cited Half-Life:8.8; Citing Half-Life:6.8; % of OA Gold:1; Publisher name:TAYLOR & FRANCIS LTD; Publisher address:2-4 PARK SQUARE, MILTON PARK, ABINGDON, England, OXON, O
投票 ESCI期刊JMIR Cancer 2024/2025影響因子:3.386 (JMIR CANCER) (2369-1999). (ONCOLOGY)(腫瘤學(xué))Emerging Sources Citation Index  ...234
Total Citations:789; 2023 JIF:3.386; JIFRank: 118/322 ; Rank-JIF: 118; Number-of-JIF:322; 5 Year JIF:3.124; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.2; Immediacy Index:0.3; Immediacy Index-dealt:0.359; 2023 JCI:0.66; JCI Rank: 161/322 ; Total Articles:51; JCI Quartile:Q2; JCI Percentile:50.16; Eigenfactor:0.002; Normalized Eigenfactor:0.376; Article Influence Score:0.979; JIF Percentile:63.5; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:57; % of Articles in Citable items:0.8947; Cited Half-Life:2.8; Citing Half-Life:5.6; % of OA Gold:0.9842; Publisher name:ELSEVIER; Publisher address:RADARWEG 29, AMSTERDAM, Netherlands, 1043 NX;
投票 ESCI期刊Oncology Reviews 2024/2025影響因子:3.199 (ONCOL REV) (1970-5557). (ONCOLOGY)(腫瘤學(xué))Emerging Sources Citation Index  ...234
Total Citations:663; 2023 JIF:3.199; JIFRank: 136/322 ; Rank-JIF: 136; Number-of-JIF:322; 5 Year JIF:3.456; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.1; Immediacy Index:0.2; Immediacy Index-dealt:0.255; 2023 JCI:0.45; JCI Rank: 225/322 ; Total Articles:1; JCI Quartile:Q3; JCI Percentile:30.28; Eigenfactor:0.001; Normalized Eigenfactor:0.117; Article Influence Score:0.772; JIF Percentile:57.9; JIF Quartile:Q2; AIS Quartile:Q3; Citable Items:10; % of Articles in Citable items:0.1; Cited Half-Life:6.3; Citing Half-Life:8.8; % of OA Gold:1; Publisher name:NULL; Publisher address:NULL;
投票 ESCI期刊Breast Cancer Management 2024/2025影響因子:0.496 (BREAST CANCER MANAG) (1758-1923). (ONCOLOGY)(腫瘤學(xué))Emerging Sources C  ...234
Total Citations:80; 2023 JIF:0.496; JIFRank: 304/322 ; Rank-JIF: 304; Number-of-JIF:322; 5 Year JIF:0.787; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.3; Immediacy Index:<0.1; Immediacy Index-dealt:0.083; 2023 JCI:0.09; JCI Rank: 307/322 ; Total Articles:4; JCI Quartile:Q4; JCI Percentile:4.81; Eigenfactor:0; Normalized Eigenfactor:0.019; Article Influence Score:0.217; JIF Percentile:5.7; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:4; % of Articles in Citable items:1; Cited Half-Life:NULL; Citing Half-Life:6.1; % of OA Gold:1; Publisher name:UPV-EHU PRESS, SERV EDITORIAL; Publisher address:CAMPUS BIZKAIA, LEIOA, SPAIN, E-48940;
投票 ESCI期刊Breast Cancer-Basic and Clinical Research 2024/2025影響因子:1.831 (BREAST CANCER-BASIC) (1178-2234). (ONCOLOGY)(腫瘤學(xué))E  ...234
Total Citations:679; 2023 JIF:1.831; JIFRank: 241/322 ; Rank-JIF: 241; Number-of-JIF:322; 5 Year JIF:2.407; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.8; Immediacy Index:0.2; Immediacy Index-dealt:0.236; 2023 JCI:0.48; JCI Rank: 216/322 ; Total Articles:12; JCI Quartile:Q3; JCI Percentile:33.07; Eigenfactor:0.001; Normalized Eigenfactor:0.123; Article Influence Score:0.563; JIF Percentile:25.3; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:18; % of Articles in Citable items:0.6667; Cited Half-Life:7.1; Citing Half-Life:6.7; % of OA Gold:0.9672; Publisher name:WILEY; Publisher address:111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774;
投票 ESCI期刊Journal of Cancer Epidemiology 2024/2025影響因子:1.886 (J CANCER EPIDEMIOL) (1687-8558). (ONCOLOGY)(腫瘤學(xué))Emerging Sour  ...234
Total Citations:443; 2023 JIF:1.886; JIFRank: 241/322 ; Rank-JIF: 241; Number-of-JIF:322; 5 Year JIF:2.52; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.8; Immediacy Index:<0.1; Immediacy Index-dealt:0.074; 2023 JCI:0.37; JCI Rank: 251/322 ; Total Articles:3; JCI Quartile:Q4; JCI Percentile:22.2; Eigenfactor:0; Normalized Eigenfactor:1.252; Article Influence Score:0.638; JIF Percentile:25.3; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:3; % of Articles in Citable items:1; Cited Half-Life:9.7; Citing Half-Life:10.6; % of OA Gold:1; Publisher name:ROYAL SOC CHEMISTRY; Publisher address:THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRID
下一頁 »
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-4 23:58
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
返回頂部 返回版塊
北辰区| 平果县| 和硕县| 新疆| 平定县| 肥东县| 贵阳市| 乐陵市| 凤冈县| 休宁县| 固原市| 永嘉县| 红河县| 庄河市| 利川市| 蒙山县| 甘肃省| 富蕴县| 大余县| 黄梅县| 平江县| 中山市| 通江县| 昆明市| 夏河县| 香港 | 杭锦旗| 江永县| 南汇区| 嘉定区| 鹰潭市| 沂源县| 齐齐哈尔市| 富阳市| 开化县| 南涧| 寻乌县| 安岳县| 调兵山市| 阿瓦提县| 交城县|